Ipsen Pharma GmbH

Ipsen is a mid‑sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, Ipsen Pharma GmbH tackles areas of high unmet medical need through research and innovation. The company is dedicated to bringing medicines to patients in 88 countries, fostering a culture of collaboration and excellence.